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Take home message (255 of 256 character incl. spaces): After rhinovirus (RV) 
infection, RV viral loads are higher and immune factor expressions lower in nasal 
epithelial cells from children versus adults in vitro. This may explain age-dependent 
severity of RV infections and association with asthma development. 
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To the editor: 
Rhinovirus (RV)-induced wheezing in early childhood is a major risk factor for later 
asthma (1, 2) and RV-infections have been identified as a main reason for asthma 
exacerbations (3-5). While RV-infections can manifest with a severe clinical course, 
RVs can also colonize the respiratory tract asymptomatically (6-8). Thus, additional 
factors seem to determine which children develop a symptomatic RV-infection and 
are at increased risk for asthma development, and which remain asymptomatic. For 
example, there is a genetic susceptibility, since RV-induced wheezing and specific 
genetic variants increase the risk for asthma (9). Environmental factors, such as 
farming and air pollution, have been shown to influence the risk for asthma 
development (10). Further, the age of RV-infection differently affects the clinical 
course, suggesting different time windows of susceptibility (1). For example, RV-
induced wheezing at ages 2-3 years is associated with a higher risk for asthma 
development compared to wheezing during the first year of life (1), indicating age-
dependent immune responses. However, underlying mechanisms responsible for 
age-dependent severity of RV-infections have not yet been studied comprehensively. 
Therefore, we investigated age-dependency of anti-RV response in primary epithelial 
cells (NECs), which are the main target for RV-infections and act as a switchboard to 
initiate and regulate immune responses (11, 12). We hypothesize that the initial 
response of NECs to RVs is weaker at younger ages. To test this, we investigated 
the age-dependency of viral loads and the early epithelial immune response to in 
vitro infection with RV-16 and RV-1b of re-differentiated NECs of children and adults. 
 
NECs were obtained via nasal brushings (interdental brush, Top Caredent) from 
healthy adult volunteers and healthy children undergoing elective surgery (13) (study 
approved by the Ethics Committee Nordwest- und Zentralschweiz, Switzerland, 
reference number 250/13, written informed consent obtained from all donors). After 
cultivation and re-differentiation using the PneumCult Expansion Plus and ALI media 
(Stemcell Technologies), NECs were infected with RV-16 or RV-1b (multiplicity of 
infection (MOI) 1 and 4; 1h, 37°C; polyinosinic: polycytidylic acid (pI:C) (10μg/ml) and 
phosphate-buffered saline with Mg/Ca were used as controls). 20h post-infection, we 
harvested basolateral supernatants and cell lysates (using TRizol). 
mRNA was isolated (RNA Clean & Concentrator-5 w/ Zymo-Spin IC Columns, Zymo 
Research) and converted into cDNA (GoScript Reverse Transcription System, 
Promega). Real-time RT-PCR was performed using the GoTaq qPCR Master Mix 
system (Promega). Protein concentrations were measured in the basolateral media 
using a Milliplex MAP kit (Merck).  
We subdivided the paediatric population into three groups: infancy (0-12 months, 
group 1, mean age (range) 8.0 (2.5-12.7) months), early ( 13-36 months, group 2, 
26.4 (13.3-35.5) months), and late childhood (>36-93 months, group 3, 62.2 (36.3-
92.7) months). Comparison of outcomes between children (N=49, (mean age 
(range)) (3.4 (0.21-7.7) years) versus adults (N=12, (35.1 (24.9-65.6) years) was 
done using the Wilcoxon rank-sum test. A p-value <0.05 defined statistical 
significance, analysis was performed with Stata®, release 15. 
 
Re-differentiated, air-liquid-interface (ALI) exposed NECs of children showed higher 
viral loads after RV-1b and RV-16 infection than NECs of adults. This finding was 
more pronounced in cells infected with RV-16 compared to RV-1b and those infected 
at higher MOI (Fig.A). In the paediatric population, levels of viral loads after RV-16 
infection increased with increasing age, albeit not significantly (Fig.B), RV-1b 
infection showed a similar pattern (data not shown). In children and adults 
separately, we could show a robust, dose-dependent anti-viral response induced by 
RV-infection (increase of ICAM-1, LDLR, RIG-1, MDA5, TLR3, β-Def2, IFN-β, IFN-λ 
(only for RV-16), CXCL10, IL-1β (only for RV-16), CXCL8 (only for RV-16), IL-6 
mRNA and CXCL10, CXCL8 and IL-6, but not IFN-γ protein, data not shown), and 
observed differences of the anti-RV response between adults children. Interestingly, 
those differences were already present at baseline (in uninfected controls). We found 
significantly lower mRNA levels of ICAM-1, LDLR, β-DEF2, CXCL10, IL-1β, IL-6 and 
IFN-λ (only borderline significant) in children compared to adults, while mRNA levels 
of MDA5 were significantly higher in children compared to adults. We did not find any 
differences between children and adult NECs in mRNA levels of RIG1, TRL3, IFN-β, 
IFN-λ (Fig.C). These differences persisted after infection (data not shown). 
Compared to children, protein concentrations of IFN-γ and IL-6 were higher in adults 
at baseline, but not after infection. We did not see differences in CXCL10 or CXCL8 
protein concentrations (Fig.D). Within the paediatric age groups, expression levels 
and protein release did not differ significantly. 
 
This is the first study to investigate RV-1b and RV-16 infection in an ALI cell culture 
model. We found lower viral loads in cells infected with RV-1b compared to RV-16. 
Cell entry of RV-16 occurs via the ICAM-1 cell surface receptor, while RV-1b enters 
via the LDLR receptor (14). We found that compared to the highly expressed ICAM-1 
levels, LDLR expression levels were much lower, possibly explaining the reduced 
RV-1b mRNA levels found in this study. Expression levels of ICAM-1 and LDLR 
mRNA levels were higher in adults compared to children. Association between age 
and the expression of ICAM-1 or LDLR has scarcely been studied. Within a study 
including 29 adults (age 42-85 years), there was no association with age and ICAM-1 
levels (15). The here reported age-dependent expression of ICAM-1 and LDLR could 
be relevant for epidemiological and experimental studies addressing a large age-
range.  
The childhood origins of asthma (COAST) study investigated the timing and specific 
viral aetiology of wheezing illnesses during early childhood and the impact on asthma 
development within a high-risk population. These data suggest that the age of RV-
infection has prognostic value for subsequent asthma risk. Children who had RV-
induced wheezing during their first year of life had a 2.7-fold asthma risk at six years, 
while RV-induced wheezing during the second year was associated with a 6.5-fold 
asthma risk, and RV-induced wheezing during the third year was associated with a 
dramatic 31.7-fold asthma risk (1). Interestingly, we found lower viral load in infants 
compared to older children potentially reflecting the age-dependent associations 
reported previously (1). Our findings, along with those previously reported (1), are 
important for future intervention studies addressing RV-infections as age-dependent 
differences in ant-viral responses in epithelial cells. 
Our study is the first to investigate immune factors following RV-infection using an 
ALI cell model within a large population across a broad age range. Previous studies 
investigated either RV-16 or RV-1b, while we investigated both virus types in parallel, 
allowing comparison of immune response to both RV types. The study is limited by 
the cross-sectional assessment of the immune response, precluding the analysis of 
individual immune development or course of infection. Other cell types and viruses 
should be studied to investigate not only the anti-viral response to RV represented by 
the respiratory epithelium, but more comprehensively the innate and late immune 
response. 
We report on age-dependent anti-viral response in NECs after infection with major 
and minor group RVs. Children had higher viral loads than adults, likely the result of 
lower levels of immune factors. These findings may explain age-dependent severity 
of RV-infections and age-dependent associations between RV-induced wheezing 
and asthma development and indicate that early immune function priming is relevant 
for later chronic airway disease.  
 
Figure. (A&B) Viral loads of RV-1b and RV-16 in NECs 20 h post-infection 
measured by quantitative real-time RT-PCR. (A) Comparison of viral loads in 
NECs of children (n=48) and adults (n=12). (B) Comparison of viral loads after RV-16 
infection in different paediatric age groups and adults. Group 1 n=10, group 2 n=14, 
group 3 n=25, group 4 adults n=12. (C) mRNA levels of immune factors at 
baseline (without RV infection). mRNA levels are presented as dCt values, 
normalized to the house-keeping gene phosphoglycerate kinase 1. (D) Baseline 
protein concentrations assessed using multiplex bead-based immunoassays. 
Data are shown as box and whisker plot with line at median, interquartile range (box) 
and range (line). *p<0.05, tested with Wilcoxon test.  
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